Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...
Medical Device Network on MSN
Enodia raises seed funding to advance protein degradation platform
Enodia Therapeutics has raised €20.7m ($25m) in seed funding to advance a small-molecule platform for targeted protein ...
2don MSN
Boosting the cell's own cleanup: New class of small molecules accelerate natural protein degradation
Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...
1don MSN
How major nuclear protein complexes control specialized gene regulation in cancer and beyond
Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...
Proteins are biology’s molecular machines. They’re our bodies’ construction workers—making muscle, bone, and brain; regulators—keeping systems in check; and local internet—responsible for the ...
Researchers have found a new way to optimise the design of molecular motors, bringing us one step closer to making synthetic molecular machines a reality Ribbon diagram of the structure of a protein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback